Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Availability of Illegal Drugs During the COVID-19 Pandemic in Western Germany
Norbert Scherbaum, Udo Bonnet, Henning Hafermann, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study
David Otiashvili, Tamar Mgebrishvili, Ada Beselia, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 41
Changes in self-reported cannabis use during the COVID-19 pandemic: a scoping review
Kamna Mehra, Jennifer Rup, Jessica L. Wiese, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Emerging substance abuse trends in Jammu & Kashmir: shifts, forensic challenges and strategic responses
Sami Ullah, Fazlullah Khan
Forensic Research & Criminology International Journal (2025) Vol. 13, Iss. 1, pp. 21-28
Open Access
Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping review
Udo Bonnet, Michael Specka, Patrik Roser, et al.
Journal of Neural Transmission (2022) Vol. 130, Iss. 1, pp. 7-18
Open Access | Times Cited: 15
Assessment of restriction measures implemented during COVID pandemics on community lifestyle choices via wastewater-based epidemiology
Nicola Ceolotto, Kishore Jagadeesan, Like Xu, et al.
Journal of Hazardous Materials (2024) Vol. 471, pp. 134264-134264
Open Access | Times Cited: 3
Impact of the COVID-19 pandemic in the Portuguese population: Consumption of alcohol, stimulant drinks, illegal substances, and pharmaceuticals
Sara Fernandes, Milaydis Sosa‐Napolskij, Graça Lobo, et al.
PLoS ONE (2021) Vol. 16, Iss. 11, pp. e0260322-e0260322
Open Access | Times Cited: 19
Changes in Online Illegal Drug Buying during COVID-19: Assessing Effects due to a Changing Market or Changes in Strain using a Longitudinal Sample Design
James E.Hawdon, Katalin Parti, Thomas E. Dearden
American Journal of Criminal Justice (2022) Vol. 47, Iss. 4, pp. 712-734
Open Access | Times Cited: 13
Substitutionsbehandlung Opioidabhängiger unter den Bedingungen der COVID-19 Pandemie – Regionale Ergebnisse aus Nordrhein
Henrike Schecke, Michael Specka, Daniel Deimel, et al.
Suchttherapie (2024) Vol. 25, Iss. 01, pp. 16-21
Closed Access | Times Cited: 2
COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis
Davide Arillotta, Amira Guirguis, John Corkery, et al.
Brain Sciences (2021) Vol. 11, Iss. 7, pp. 907-907
Open Access | Times Cited: 16
Drug consumption in German cities and municipalities during the COVID-19 lockdown: a wastewater analysis
Reinhard Oertel, Sara Schubert, Björn Helm, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 5, pp. 1061-1074
Open Access | Times Cited: 6
Letter to the editor: Other Consequences. COVID-19 and underestimated public health crisis
Anastasia Peshkovskaya
Journal of Psychiatric Research (2021) Vol. 144, pp. 320-322
Open Access | Times Cited: 11
Impulsivity as a Risk Factor for Addictive Disorder Severity during the COVID-19 Lockdown: Results from a Mixed Quantitative and Qualitative Study
Maxime Pautrat, Antoine Le Guen, Servane Barrault, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 20, Iss. 1, pp. 705-705
Open Access | Times Cited: 8
Frequency and patterns of substance-induced psychosis in persons with concurrent mental health and substance use disorders during the COVID-19 pandemic: A Norwegian register-based cohort study
Marja Leonhardt, Jørgen G. Bramness, Eline Borger Rognli, et al.
European Psychiatry (2024) Vol. 67, Iss. 1
Open Access | Times Cited: 1
Insights into the Experiences of Persons with Substance Use Disorders During COVID-19 Lockdown in Lagos, Nigeria: A Qualitative Investigation
Samuel Ojima Adejoh, Peter Osazuwa, Sofiat Busari-Akinbode, et al.
Substance Use Research and Treatment (2024) Vol. 18
Closed Access | Times Cited: 1
Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland
Ahmed Al-Imam, Marek Motyka, Zuzanna Witulska, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 11, pp. 6619-6619
Open Access | Times Cited: 6
The Scale of Intoxications with New Psychoactive Substances over the Period 2014–2020—Characteristics of the Trends and Impacts of the COVID-19 Pandemic on the Example of Łódź Province, Poland
Anna Garus-Pakowska, Agnieszka Kolmaga, Ewelina Gaszyńska, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 8, pp. 4427-4427
Open Access | Times Cited: 4
“The Drug Sellers Were Better Organized than the Government”: A Qualitative Study of Participants’ Views of Drug Markets during COVID-19 and Other Big Events
Roberto Abadie
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 2, pp. 1295-1295
Open Access | Times Cited: 2
Associations between mental health challenges, sexual activity, alcohol consumption, use of other psychoactive substances and use of COVID-19 preventive measures during the first wave of the COVID-19 pandemic by adults in Nigeria
Morẹ́nikẹ́ Oluwátóyìn Foláyan, Olanrewaju Ibıgbamı, Maha El Tantawi, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Restrictive measures and substance use reporting: New evidence from the COVID-19 pandemic
Andrea Rebucini, Federica Origo, Francesca Schionato, et al.
International Journal of Drug Policy (2023) Vol. 122, pp. 104238-104238
Closed Access | Times Cited: 1
Trajectories of Young People’s Cannabis Use During the COVID-19 Pandemic in Germany
Ronja Kleine, Júlia Hansen, Frauke Nees, et al.
SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice (2024) Vol. 70, Iss. 3, pp. 133-142
Closed Access
Advancing toxicovigilance of recreational drugs, including new psychoactive substances, by using data from four European poison centres
A. Karim Kader, Maren Hermanns‐Clausen, Antoinette van Riel, et al.
Clinical Toxicology (2024), pp. 1-9
Open Access
Consumption patterns before and during the COVID-19 pandemic among patients admitted to inpatient drug detoxification treatment: Results of two cross-sectional surveys from 2018 and 2021
Patrik Roser, Michael Specka, Udo Bonnet, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access
Negotiating an Illicit Economy in the Time of COVID-19: Selling and Buying Dilemmas in the Lives of People Who Use Drugs in Scotland
Angus Bancroft, Tessa Parkes, Idil Galip, et al.
Contemporary Drug Problems (2022) Vol. 49, Iss. 4, pp. 369-384
Open Access | Times Cited: 1
Dynamics of detection of narcotic compounds for 2013-2021: a case study of the Republic of Bashkortostan
I. S. Efremov, Елена Викторовна Галеева, I. V. Nikolaev, et al.
RESEARCH RESULTS IN BIOMEDICINE (2023) Vol. 9, Iss. 3
Open Access
Positive impacts of COVID-19 Lock down in Bangladesh: An online investigation
Md. Galib Ishraq Emran, Khandaker Tanveer Ahmed, Al-Shahriar Khan, et al.
Heliyon (2023) Vol. 9, Iss. 10, pp. e20487-e20487
Open Access
Page 1 - Next Page

Scroll to top